{"rows":[{"id":4682,"title":"The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages","authors":"Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk","journal":"Psychoactives","publication_date":"2024-01-28","publication_year":2024,"doi":"10.3390/psychoactives3010004","pubmed_id":null,"openalex_id":"https://openalex.org/W4391340931","source_url":"https://doi.org/10.3390/psychoactives3010004","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,In Vitro Study,Inflammation","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-08-09 08:25:31","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives3010004","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives3010004","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives3010004","source_url":"https://doi.org/10.3390/psychoactives3010004","doi":"10.3390/psychoactives3010004","pmid":"","publication_date":"2024-01-28","importer_version":"2.1.3","text_redistributed":false}},{"id":4639,"title":"Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression","authors":"Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden","journal":"Psychoactives","publication_date":"2024-04-15","publication_year":2024,"doi":"10.3390/psychoactives3020014","pubmed_id":null,"openalex_id":"https://openalex.org/W4394855468","source_url":"https://doi.org/10.3390/psychoactives3020014","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Review Article,Safety","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-07-04 06:34:43","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives3020014","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives3020014","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives3020014","source_url":"https://doi.org/10.3390/psychoactives3020014","doi":"10.3390/psychoactives3020014","pmid":"","publication_date":"2024-04-15","importer_version":"2.1.3","text_redistributed":false}},{"id":4612,"title":"Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress","authors":"Sean M. Viña","journal":"Psychoactives","publication_date":"2024-06-02","publication_year":2024,"doi":"10.3390/psychoactives3020019","pubmed_id":null,"openalex_id":"https://openalex.org/W4399304220","source_url":"https://doi.org/10.3390/psychoactives3020019","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Observational Study","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:29","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives3020019","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives3020019","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives3020019","source_url":"https://doi.org/10.3390/psychoactives3020019","doi":"10.3390/psychoactives3020019","pmid":"","publication_date":"2024-06-02","importer_version":"2.1.3","text_redistributed":false}},{"id":4542,"title":"Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis","authors":"Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar","journal":"Psychoactives","publication_date":"2024-10-03","publication_year":2024,"doi":"10.3390/psychoactives3040029","pubmed_id":null,"openalex_id":"https://openalex.org/W4403113128","source_url":"https://doi.org/10.3390/psychoactives3040029","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Pharmacology,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:42","last_checked":"2026-07-04 07:00:34","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives3040029","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives3040029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives3040029","source_url":"https://doi.org/10.3390/psychoactives3040029","doi":"10.3390/psychoactives3040029","pmid":"","publication_date":"2024-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":4442,"title":"Funding Success of United States Federal Grant Applications Proposing to Study Therapeutic Applications of Psychedelics: A Survey Study","authors":"Brian S. Barnett","journal":"Psychoactives","publication_date":"2025-02-05","publication_year":2025,"doi":"10.3390/psychoactives4010004","pubmed_id":null,"openalex_id":"https://openalex.org/W4407177057","source_url":"https://doi.org/10.3390/psychoactives4010004","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:23","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4010004","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4010004","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4010004","source_url":"https://doi.org/10.3390/psychoactives4010004","doi":"10.3390/psychoactives4010004","pmid":"","publication_date":"2025-02-05","importer_version":"2.1.3","text_redistributed":false}},{"id":4441,"title":"Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle?","authors":"Bor Luen Tang","journal":"Psychoactives","publication_date":"2025-02-06","publication_year":2025,"doi":"10.3390/psychoactives4010005","pubmed_id":null,"openalex_id":"https://openalex.org/W4407194293","source_url":"https://doi.org/10.3390/psychoactives4010005","substance_tags":"psilocybin","topic_tags":"Safety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:23","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4010005","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4010005","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4010005","source_url":"https://doi.org/10.3390/psychoactives4010005","doi":"10.3390/psychoactives4010005","pmid":"","publication_date":"2025-02-06","importer_version":"2.1.3","text_redistributed":false}},{"id":4391,"title":"Regulatory Challenges of Integrating Psychedelics into Mental Health Sector","authors":"Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher","journal":"Psychoactives","publication_date":"2025-04-22","publication_year":2025,"doi":"10.3390/psychoactives4020011","pubmed_id":null,"openalex_id":"https://openalex.org/W4409667310","source_url":"https://doi.org/10.3390/psychoactives4020011","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Receptor Pharmacology,Review Article","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:40","last_checked":"2026-08-09 08:25:21","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4020011","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4020011","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4020011","source_url":"https://doi.org/10.3390/psychoactives4020011","doi":"10.3390/psychoactives4020011","pmid":"","publication_date":"2025-04-22","importer_version":"2.1.3","text_redistributed":false}},{"id":4356,"title":"Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics","authors":"Mathieu Fradet","journal":"Psychoactives","publication_date":"2025-06-29","publication_year":2025,"doi":"10.3390/psychoactives4030021","pubmed_id":null,"openalex_id":"https://openalex.org/W4411824807","source_url":"https://doi.org/10.3390/psychoactives4030021","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-08-09 08:25:19","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4030021","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4030021","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4030021","source_url":"https://doi.org/10.3390/psychoactives4030021","doi":"10.3390/psychoactives4030021","pmid":"","publication_date":"2025-06-29","importer_version":"2.1.3","text_redistributed":false}},{"id":4352,"title":"Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report","authors":"David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison","journal":"Psychoactives","publication_date":"2025-07-01","publication_year":2025,"doi":"10.3390/psychoactives4030022","pubmed_id":null,"openalex_id":"https://openalex.org/W4411885403","source_url":"https://doi.org/10.3390/psychoactives4030022","substance_tags":"psilocybin","topic_tags":"Headache / Migraine,Receptor Pharmacology,Aging,Case Report,Healthcare Workers,Safety","study_type":"Case Report","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-08-09 08:25:19","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4030022","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4030022","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4030022","source_url":"https://doi.org/10.3390/psychoactives4030022","doi":"10.3390/psychoactives4030022","pmid":"","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4305,"title":"Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report","authors":"M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler","journal":"Psychoactives","publication_date":"2025-09-01","publication_year":2025,"doi":"10.3390/psychoactives4030030","pubmed_id":null,"openalex_id":"https://openalex.org/W4413893315","source_url":"https://doi.org/10.3390/psychoactives4030030","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Mechanism of Action,Case Report,Safety","study_type":"Case Report","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-08-09 08:25:17","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4030030","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4030030","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4030030","source_url":"https://doi.org/10.3390/psychoactives4030030","doi":"10.3390/psychoactives4030030","pmid":"","publication_date":"2025-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4298,"title":"Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care","authors":"Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher","journal":"Psychoactives","publication_date":"2025-09-02","publication_year":2025,"doi":"10.3390/psychoactives4030031","pubmed_id":null,"openalex_id":"https://openalex.org/W4413908189","source_url":"https://doi.org/10.3390/psychoactives4030031","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Receptor Pharmacology,Wellbeing,Resilience,Emotional Processing,Review Article,Safety,Inflammation","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-08-09 08:25:17","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4030031","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4030031","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4030031","source_url":"https://doi.org/10.3390/psychoactives4030031","doi":"10.3390/psychoactives4030031","pmid":"","publication_date":"2025-09-02","importer_version":"2.1.3","text_redistributed":false}},{"id":4296,"title":"The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting","authors":"Tereza Dleštíková","journal":"Psychoactives","publication_date":"2025-09-11","publication_year":2025,"doi":"10.3390/psychoactives4030034","pubmed_id":null,"openalex_id":"https://openalex.org/W4414123257","source_url":"https://doi.org/10.3390/psychoactives4030034","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Safety","study_type":"Qualitative Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-08-09 08:25:17","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4030034","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4030034","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4030034","source_url":"https://doi.org/10.3390/psychoactives4030034","doi":"10.3390/psychoactives4030034","pmid":"","publication_date":"2025-09-11","importer_version":"2.1.3","text_redistributed":false}},{"id":4249,"title":"Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy","authors":"Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli","journal":"Psychoactives","publication_date":"2025-11-02","publication_year":2025,"doi":"10.3390/psychoactives4040039","pubmed_id":null,"openalex_id":"https://openalex.org/W4415817857","source_url":"https://doi.org/10.3390/psychoactives4040039","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Neuroplasticity,Pharmacology,Receptor Pharmacology,Longevity,Review Article,Animal Study,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-08-09 08:25:16","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4040039","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4040039","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4040039","source_url":"https://doi.org/10.3390/psychoactives4040039","doi":"10.3390/psychoactives4040039","pmid":"","publication_date":"2025-11-02","importer_version":"2.1.3","text_redistributed":false}},{"id":4242,"title":"A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens","authors":"William Roseby, Catriona Osborn Moar","journal":"Psychoactives","publication_date":"2025-11-14","publication_year":2025,"doi":"10.3390/psychoactives4040041","pubmed_id":null,"openalex_id":"https://openalex.org/W4416229569","source_url":"https://doi.org/10.3390/psychoactives4040041","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Brain Imaging,Consciousness,Aging,Psychological Flexibility,Review Article,Drug Interactions","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-08-09 08:25:15","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives4040041","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives4040041","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives4040041","source_url":"https://doi.org/10.3390/psychoactives4040041","doi":"10.3390/psychoactives4040041","pmid":"","publication_date":"2025-11-14","importer_version":"2.1.3","text_redistributed":false}},{"id":4017,"title":"Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care","authors":"Sean M. Viña","journal":"Psychoactives","publication_date":"2026-05-11","publication_year":2026,"doi":"10.3390/psychoactives5020014","pubmed_id":null,"openalex_id":"https://openalex.org/W7160952638","source_url":"https://doi.org/10.3390/psychoactives5020014","substance_tags":"psilocybin","topic_tags":"Depression,Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:35","last_checked":"2026-07-04 06:34:35","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives5020014","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/psychoactives5020014","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychoactives5020014","source_url":"https://doi.org/10.3390/psychoactives5020014","doi":"10.3390/psychoactives5020014","pmid":"","publication_date":"2026-05-11","importer_version":"2.1.3","text_redistributed":false}},{"id":1970,"title":"Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol","authors":"Penberthy J. Kim, A. Wise Fatma, Cherup Nicholas, Penberthy J. Morgan, Mitchell Evaline, Burns Madeline, Akinlade Oluwafunmilayo, Chung David, Parmar Harshit, Singer Jonathan","journal":"Psychoactives","publication_date":"2026-04-13","publication_year":2026,"doi":"10.3390/psychoactives5020012","pubmed_id":null,"openalex_id":"https://openalex.org/W7153973756","source_url":"https://doi.org/10.3390/psychoactives5020012","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Randomized Controlled Trial,Safety","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:28:48","bibtex":null,"source_record_id":"DOI:10.3390/psychoactives5020012","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/psychoactives5020012","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/psychoactives5020012","source_url":"https://doi.org/10.3390/psychoactives5020012","doi":"10.3390/psychoactives5020012","pmid":"","publication_date":"2026-04-13","importer_version":"2.1.3","text_redistributed":false}}],"total":16,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Psychoactives","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}